Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
about
Lipid accumulation and dendritic cell dysfunction in cancerInhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinRecommendations for myeloid-derived suppressor cell nomenclature and characterization standardsRegulation of Natural Killer Cell Function by STAT3The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentTumor-infiltrating dendritic cells in cancer pathogenesisControl of the immune response by pro-angiogenic factorsRegulation of tumor metastasis by myeloid-derived suppressor cellsDiversification of dendritic cell subsets: Emerging roles for STAT proteinsSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyInterference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma HerpesvirusesMyeloid-derived suppressor cells as regulators of the immune systemThe Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentPathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancerCoordinated regulation of myeloid cells by tumoursBovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cellsImmunosuppressive strategies that are mediated by tumor cellsThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBMMembrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsThe innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling.Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.Targeting immune suppressing myeloid-derived suppressor cells in oncology.Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentHIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cellsTumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathwayAZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells.Dendritic cell activation by glucan isolated from umbilicaria esculentaTumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.Tumor antigen-dependent and tumor antigen-independent activation of antitumor activity in T cells by a bispecific antibody-modified tumor vaccine.
P2860
Q23912213-845DE6F5-79BF-45DA-B119-892BA431FF1EQ24641894-3D42071F-3C8B-4738-9407-51CF56B9B3F2Q26744395-AFD043AA-F36E-416B-BB8D-5BA62F97C25FQ26752551-EBBD6254-291E-44AC-A30E-AB381EEDD012Q26799120-BCEB7804-7116-490A-A07C-763FF9947FD1Q26799126-3C7440A2-6C02-4DC9-910F-2FC7F9ED0663Q26861633-4F477B2E-5A78-47BA-AF57-7F3B13C983F6Q27004733-28478980-E69D-4E56-B0DC-6B8472222681Q27022125-025C24E2-6082-4AEA-A2B1-B22C486624B6Q27022894-61BB9D3A-DE9D-4CEE-964C-0AB6A99CD5DFQ28080262-A8C0959F-BE5B-4D4D-9BD6-60F759926AC6Q28080898-C1D0DDA1-D4C8-4778-A4A8-BBB2C8B02F44Q28131637-1E38081B-3229-4265-844B-C0D88234E32FQ28388630-1B786B57-7F81-4826-AB26-BB53E4BCF4F2Q28392626-1CD12AFD-5F8C-4E25-87BD-D693A7134C06Q28395157-30F19F3A-490E-4718-A2D7-13049D5B5432Q28742177-03178D20-F870-43AF-850A-5F62C5EACA55Q29636247-111748DA-CADB-4B44-9C43-9BD6F799AD6CQ30317628-42A27F92-821D-4F3B-9A0F-2AB66F01106BQ30411008-ECC26EF3-C889-49A0-9A43-06FDADA20B46Q33541021-01E9B960-2AFE-4CE6-8FC6-9C683E9957ADQ33578030-CB4B1293-2DED-4549-865D-FBDB32CFE057Q33604925-1FB02611-71A7-4DAC-8913-C068601CA9F4Q33660069-B58BAA21-0049-4761-A8E1-15180FECCBA5Q33707270-2CA513A6-C4CA-448A-BE16-1E93DE257923Q33733198-CFC74E38-BB95-467C-BE7F-68848DFD7706Q33754157-D12CF19C-511E-4602-A083-1A7D9B78F1BCQ33772651-10289816-F6CE-462F-8D95-DEE5B80BED68Q33839267-3694B37A-063D-4BD0-A87C-CF652E17510CQ33979918-C3ED3C91-601B-4520-B25A-0B87007D2688Q34082067-431B617D-89DF-4A2B-A0E7-DDC829F17CADQ34113544-774711E8-D89E-409D-9BE8-F7CAC728F171Q34243443-8ABE6730-17DE-4BE5-B397-9A68C483EB2AQ34261887-BF1C5838-6ADD-450C-924F-A688F3E50962Q34312635-FB9019BF-4E15-450F-8483-67555F362594Q34314210-C14B6CAF-CFD0-4C11-B109-C5B0FDB1F26EQ34334399-51C49018-4B32-456C-A3AA-4F8C7671CD41Q34521014-A89BCF69-5A42-40ED-8BD8-24059720EDEBQ34525342-1A62F705-FAE4-4D9D-A5E1-D3B3C67894A6Q34626956-9DC296C9-BF5C-4501-86C9-D3069066023E
P2860
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hyperactivation of STAT3 is in ...... of dendritic cells in cancer.
@en
type
label
Hyperactivation of STAT3 is in ...... of dendritic cells in cancer.
@en
prefLabel
Hyperactivation of STAT3 is in ...... of dendritic cells in cancer.
@en
P2093
P1476
Hyperactivation of STAT3 is in ...... n of dendritic cells in cancer
@en
P2093
Dmitry Gabrilovich
Pingyan Cheng
Raka Bhattacharya
Raoul Salup
Richard Jove
Yulia Nefedova
P304
P356
10.4049/JIMMUNOL.172.1.464
P407
P50
P577
2004-01-01T00:00:00Z